Title	Publication Date	Language	Citations
Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes	1999/02/01	English	123
Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus	2010/04/07	English	123
Systemic lupus erythematosus and the risk of malignancy	2001/06/01	English	122
Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies	2002/03/01	English	122
Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients	2004/05/01	English	122
Previous antimalarial therapy in patients diagnosed with lupus nephritis: Influence on outcomes and survival	2008/04/01	English	121
Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis	2009/07/03	English	121
The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe	2009/08/11	English	121
Depression and systemic lupus erythematosus: a systematic review	2013/02/20	English	120
Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases	1996/06/01	English	119
Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine	2005/04/01	English	117
A study of 20 SLE patients with intravenous immunoglobulin clinical and serologic response	1999/11/01	English	116
Epidemiology and socioeconomic impact of skin disease in lupus erythematosus	1997/02/01	English	115
Vitamin D insufficiency in a large female SLE cohort	2009/11/06	English	114
Polyarteritis nodosa, microscopic polyangiitis and Churg–Strauss syndrome	1998/05/01	English	113
Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups	1997/03/01	English	113
Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis	1998/01/01	English	113
Baseline characteristics of a multiethnic lupus cohort: PROFILE	2002/03/01		112
Review: Male systemic lupus erythematosus: a review of sex disparities in this disease	2009/11/27	English	112
Endpoints: consensus recommendations from OMERACT IV	2000/06/01	English	112
Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy	2000/07/01	English	112
Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features	2003/11/01	English	111
The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis	2012/08/14	English	111
‘Non-criteria’ aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010	2011/02/01	English	110
Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome?	1995/04/01	English	109
Diet, microbiota and autoimmune diseases	2014/04/24	English	109
Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus	1999/05/01	English	109
Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis	2011/09/27	English	108
Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement	2000/09/01	English	107
Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes	2013/10/01	English	107